Benchmark Increases Select Medical (NYSE:SEM) Price Target to $48.00

Select Medical (NYSE:SEM) had its price objective raised by Benchmark from $42.00 to $48.00 in a research report issued on Tuesday, Benzinga reports. The brokerage currently has a “buy” rating on the health services provider’s stock. Benchmark’s target price would indicate a potential upside of 22.39% from the company’s previous close.

Several other equities analysts have also recently weighed in on SEM. StockNews.com raised shares of Select Medical from a “hold” rating to a “buy” rating in a research note on Friday, March 22nd. Royal Bank of Canada raised their target price on shares of Select Medical from $36.00 to $40.00 and gave the company an “outperform” rating in a research report on Monday, May 6th. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $36.50.

Select Medical Trading Up 1.7 %

SEM opened at $39.22 on Tuesday. The stock has a market capitalization of $5.10 billion, a P/E ratio of 18.68, a P/E/G ratio of 1.79 and a beta of 1.43. The company has a current ratio of 1.22, a quick ratio of 1.22 and a debt-to-equity ratio of 2.30. Select Medical has a 12 month low of $21.28 and a 12 month high of $39.43. The firm’s fifty day simple moving average is $34.64 and its 200 day simple moving average is $30.10.

Select Medical (NYSE:SEM) last issued its quarterly earnings results on Thursday, May 2nd. The health services provider reported $0.77 EPS for the quarter, beating analysts’ consensus estimates of $0.55 by $0.22. The company had revenue of $1.79 billion for the quarter, compared to analyst estimates of $1.70 billion. Select Medical had a return on equity of 18.11% and a net margin of 3.97%. As a group, research analysts anticipate that Select Medical will post 2.1 EPS for the current fiscal year.

Institutional Investors Weigh In On Select Medical

Several hedge funds have recently bought and sold shares of SEM. Hexagon Capital Partners LLC raised its stake in Select Medical by 528.7% in the 2nd quarter. Hexagon Capital Partners LLC now owns 767 shares of the health services provider’s stock valued at $27,000 after acquiring an additional 645 shares during the period. GAMMA Investing LLC acquired a new position in Select Medical in the 4th quarter valued at about $33,000. Fidelis Capital Partners LLC bought a new position in Select Medical in the 1st quarter valued at about $47,000. SG Americas Securities LLC acquired a new stake in Select Medical during the first quarter worth approximately $186,000. Finally, Allspring Global Investments Holdings LLC boosted its holdings in shares of Select Medical by 6.6% during the first quarter. Allspring Global Investments Holdings LLC now owns 6,563 shares of the health services provider’s stock worth $198,000 after acquiring an additional 405 shares during the period. 89.48% of the stock is currently owned by institutional investors and hedge funds.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.